Navigation Links
Ohio Injury Lawyers Support FDA's Decision for Further Testing of Transvaginal Mesh
Date:1/10/2012

MAYFIELD HEIGHTS, Ohio, Jan. 10, 2012 /PRNewswire/ -- Transvaginal mesh will undergo new safety studies, as required by the FDA. The product defect lawyers at Elk & Elk are currently investigating transvaginal mesh claims.

The Food and Drug Administration is requiring more than 30 transvaginal surgical mesh manufacturers, including Johnson & Johnson, Boston Scientific Corp. and C.R. Bard Inc., to perform post-market safety studies after a fivefold increase in the number of complications linked to these devices.

The manufacturers will study side effects of the devices, including mesh erosion, pain and infection. They must provide data on the effectiveness of transvaginal mesh implants for treating conditions like pelvic organ prolapse and stress urinary incontinence in women.

Approximately 300,000 women underwent transvaginal mesh procedures in 2010, according to the FDA, and many manufacturers are now facing lawsuits for complications involving transvaginal mesh. The Ohio injury lawyers at Elk & Elk are investigating claims for transvaginal surgical mesh injuries.

In July 2011, the FDA issued a safety communication alerting patients of the risks of transvaginal surgical mesh. The alert came after transvaginal mesh was linked to a much higher rate of complications than claimed by manufacturers.

"Now these companies are going to have to tell the truth," said Lana Keeton in an article in Bloomberg Businessweek. Keeton is a mesh recipient and patient advocate from Austin, Texas. "Up until now, there's been no data. It's all been marketing."

Transvaginal surgical mesh hasn't been adequately tested as a safe and effective treatment for POP or SUI. Elk & Elk's product defect lawyers support the FDA's decision for additional testing of transvaginal mesh devices.

If you or a loved one underwent a transvaginal mesh surgery to treat POP or SUI and are experiencing painful complications, get in touch with the Ohio injury lawyers at Elk & Elk to make sure you're fairly compensated for your injuries. Call 1-800-ELK-OHIO for a free, no-obligation case consultation.

About Elk & Elk:

Elk & Elk is one of Ohio's premier personal injury and medical malpractice law firms. It represents individuals and families in serious personal injury and wrongful death cases throughout Ohio and around the country. Its lawyers are renowned for their achievements in the courtroom and their contributions in the community. The experience and resources of the firm has resulted in exceptional results for its clients.

Contact Jay Kelley at 1-877-355-1355 x 1154 or jkelley@elkandelk.com.

 


 


'/>"/>
SOURCE Elk & Elk
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
3. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
4. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
5. Helping Families Cope After an Injury
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Novel Approach May Protect Against Heart Attack Injury
10. For Iraq Veterans, Headaches Continue After Traumatic Brain Injury
11. Orthopaedic Injury: High Risk to Pregnant Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical ... ended December 31, 2016 after market close on ... released later than the previous fiscal year,s results ... and balances of Apicore from the acquisition date ... date meets TSX Venture Exchange listed company requirements. ...
(Date:3/28/2017)... 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – Market Insights, ... and global market trends of the Chemotherapy Induced Neutropenia for the ... Europe ( France , ... , UK) and Japan , as well ... of the world (RoW). The Report covers the therapeutics ...
(Date:3/28/2017)... March 28, 2017  "US Cancer Generics Market ... various indicators and trend analysis related to the ... mainstream pharmaceutical market in US. The report analyzes ... growth on cancer generics drugs in recent years. ... of billions of dollars for various stake holders ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... ... without a referral to new patients from Burnaby, BC. Patients in need of ... mouth reconstruction services, can see the esteemed team at Wall Centre Dental. Drs. ...
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... continues developing an ANSI-approved, consensus-based American National Standard for Good Manufacturing Practices ... the first ANSI-approved GMP standard for dietary supplements this spring, is hiring ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... PITTSBURGH, PA (PRWEB) , ... March 29, 2017 ... ... and hassles associated with wearing oral braces. "The rubber bands used in conjunction ... he said, "so I decided to design a way to prevent this problem." ...
Breaking Medicine News(10 mins):